Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Brain Neoplasms 2 Thymus Neoplasms 1 Thymoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Meningioma 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Cardiotoxicity 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 39 Docetaxel 30 Tamoxifen 29 Paclitaxel 27 Doxorubicin 26 Trastuzumab 20 Radiotherapy 18 Epirubicin 16 Letrozole 13 exemestane 11 Fluorouracil 11 Anastrozole 11 Capecitabine 10 Bevacizumab 10 Immunohistochemistry 9 Filgrastim 9 Fulvestrant 8 Methotrexate 7 Gene Expression Profiling 7 palbociclib 6 Zoledronic Acid 6 Microarray Analysis 6 Lapatinib 6 Goserelin 6 Chemotherapy, Adjuvant 6 Amplified Fragment Length Polymorphism Analysis 6 Vinorelbine 5 Triptorelin Pamoate 5 Carboplatin 5 Absorptiometry, Photon 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Breast Neoplasms × Proton Therapy × Clear all

NCT05856773 2025-09-09

COMPRO

Proton Collaborative Group

Phase 3 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡